We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$592M
AUM Growth
-$30.3M
Cap. Flow
-$9.05M
Cap. Flow %
-1.53%
Top 10 Hldgs %
59.76%
Holding
37
New
3
Increased
13
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$16.9M
2
UTHR icon
United Therapeutics
UTHR
+$11.9M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$10.1M
4
ELAN icon
Elanco Animal Health
ELAN
+$6.96M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.39M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$14.6M
2
ABT icon
Abbott
ABT
+$12.7M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$12.6M
4
VTRS icon
Viatris
VTRS
+$9.61M
5
CVS icon
CVS Health
CVS
+$9.58M

Sector Composition

Rank Sector Weight
1 Healthcare 99.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PDCO
26
DELISTED
Patterson Companies, Inc.
PDCO
$8.36M 1.41%
469,255
– –
IONS icon
27
Ionis Pharmaceuticals
IONS
$9.35B
$7.88M 1.33%
131,514
– –
ALNY icon
28
Alnylam Pharmaceuticals
ALNY
$36.3B
$7.79M 1.32%
96,900
+25,000
+35% +$1.98M
RARE icon
29
Ultragenyx Pharmaceutical
RARE
$2.65B
$7.4M 1.25%
172,978
+93,325
+117% +$5.07M
PTCT icon
30
PTC Therapeutics
PTCT
$6.37B
$4.11M 0.69%
121,402
-108,096
-47% -$4.7M
PTLA
31
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.38M 0.57%
125,925
-78,000
-38% -$2.19M
AGIO icon
32
Agios Pharmaceuticals
AGIO
$2.16B
$3.33M 0.56%
102,913
– –
SGMO
33
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.28M 0.38%
251,698
– –
CLVS
34
DELISTED
Clovis Oncology, Inc.
CLVS
$1.7M 0.29%
431,425
– –
CVS icon
35
CVS Health
CVS
$137B
– –
-175,743
Closed -$9.58M
MCK icon
36
McKesson
MCK
$98.5B
– –
-44,175
Closed -$5.94M
VTRS icon
37
Viatris
VTRS
$20.1B
– –
-504,592
Closed -$9.61M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2019 Portfolio in Review

As of Q3 2019, Sector Gamma AS held 37 positions worth $592M, down 4.9% from $622M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sector Gamma AS's Q3 2019 filing shows 3 new, 13 increased, 9 reduced and 3 closed positions. Its largest new stake was Eli Lilly: 152,105 shares worth $17M. The largest sale was Biogen, an estimated $14.6M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

  • Sector Gamma AS's largest Q3 2019 buy was Eli Lilly: 152,105 shares worth $17M.
  • Sector Gamma AS added most to Elanco Animal Health in Q3 2019, an estimated $6.96M increase.
  • Sector Gamma AS's biggest Q3 2019 reduction was Biogen, cutting an estimated $14.6M.
  • Sector Gamma AS fully exited Viatris in Q3 2019, selling an estimated $9.61M.
  • Sector Gamma AS's ten largest holdings make up 60% of its $592M portfolio in Q3 2019.
  • Sector Gamma AS opened 3 new positions and closed 3 in Q3 2019.
  • Sector Gamma AS's portfolio value fell 4.9% quarter-over-quarter to $592M.

Based on Sector Gamma AS's 13F filing for Q3 2019, filed 5 Nov 2019.